Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8.

Hernandez-Caballero AI, Vierkoetter KR, Ahn HJ, Shimizu D, Terada K. Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8. Gynecol Oncol Rep. 2020 Aug; 33:100614.

View in: PubMed

authors with profiles

Hyeong Jun Ahn, PhD
Keith Terada, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support